Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HelpScript Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
Asset Publisher
Content with Policies & Guidelines Draft Provider-Administered Drug Policies .
Hizentra, Gammagard Liquid, Gamunex-C, Gammagard Liquid ERC, Gammaked, Hyqvia, Cuvitri, Cutaquig, Xembify
Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Monovisc, Orthovisc, Supartz/Supartz FX, Synojoynt, Synvisc, Synvisc-One, TriVisc, VISCO-3, Triluron, sodium hyaluronate 1%
Alyglo, Bivigam; Flebogamma; Gamunex-C; Gammagard Liquid; Gammagard S/D; Gammagard Liquid ERC; Gammaked; Gammaplex; Octagam; Privigen; Panzyga; Yimmugo
Lupron Depot, Lupron Depot-Ped, Eligard, Fensolvi, Lutrate Depot, Camcevi, Leuprolide Acetate Depot , Vabrinty
Prolia; Jubbonti; Ospomyv; Stoboclo; Denosumab-dssb; Conexxence; Denosumab-bnht; Xgeva; Wyost; Xbryk; Osenvelt; Bomyntra
Stelara, Wezlana, Selarsdi, Pyzchiva, Otulfi, Imuldosa, Yesintek, Steqeyma, Ustekinumab-aekn
Neulasta, Fulphila, Udenyca, Ziextenzo, Nyvepria; Fylnetra, Stimufend, Rolvedon, Ryzneuta, Pegfilgrastim-fpgk